Macrophage activation syndrome and other systemic inflammatory conditions after BMT

Bone Marrow Transplantation

Volumn 37, Issue 7, 2006, Pages 629-634

  Sreedharan, A ^a   Bowyer, S ^a   Wallace, C A ^b   Robertson, M J ^a   Schmidt, K ^a   Woolfrey, A E ^b   Nelson Jr , R P ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Arthritis; Autoimmunity; Engraftment syndrome; Macrophage activation syndrome; Stem cell transplantation

Indexed keywords

ACICLOVIR; ANTIRHEUMATIC AGENT; AZATHIOPRINE; CEFTAZIDIME; CLINDAMYCIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETANERCEPT; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INFLIXIMAB; MEROPENEM; METHOTREXATE; METHYLPREDNISOLONE; PENTAMIDINE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; THALIDOMIDE; THYMOCYTE ANTIBODY; VANCOMYCIN;

ADULT; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CASE REPORT; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG ERUPTION; DRUG MEGADOSE; DRUG RESPONSE; DRUG SUBSTITUTION; FEVER; HUMAN; HYPERFERRITINEMIA; IMMUNOSUPPRESSIVE TREATMENT; JUVENILE RHEUMATOID ARTHRITIS; LIVER CELL DAMAGE; MACROPHAGE ACTIVATION SYNDROME; MALE; PANCYTOPENIA; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS INFECTION; STEM CELL MOBILIZATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT FAILURE;

ADULT; ARTHRITIS, JUVENILE RHEUMATOID; AUTOIMMUNE DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFLAMMATION; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; REMISSION INDUCTION; SYNDROME;

EID: 33645243380     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705305     Document Type: Review

References (36)

1. Hadchouel M, Prieur AM, Griscelli C. Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: Possible relationship to drugs or infection. J Pediatr 1985; 106: 561-566.
2. Cahill RA, Spitzer TR, Mazumder A. Marrow engraftment and clinical manifestations of capillary leak syndrome. Bone Marrow Transplant 1996; 18: 177-184.
3. Prieur AM, Stephan JL. [Macrophage activation syndrome in rheumatic diseases in children]. Rev Rhum Ed Fr 1994; 61: 447-451.
4. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991; 18: 29-33.
5. Maiolino A, Biasoli I, Lima J, Portugal AC, Pulcheri W, Nucci M. Engraftment syndrome following autologous hematopoietic stem cell transplantation: Definition of diagnostic criteria. Bone Marrow Transplant 2003; 31: 393-397.
6. Levi M, de Jonge E, van der Poll T. New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology. Ann Med 2004; 36: 41-49.
7. Powles R, Pedrazzini A, Crofts M, Clink H, Millar J, Bhattia G et al. Mismatched family bone marrow transplantation. Semin Hematol 1984; 21: 182-187.
8. Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 893-898.
9. Gorak E, Geller N, Srinivasan R, Espinoza-Delgado I, Donohue T, Barrett AJ et al. Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: Incidence and effects on survival. Biol Blood Marrow Transplant 2005; 11: 542-550.
10. Henter JI, Samuelsson-Horne A, Arico M, Egeler RM, Elinder G, Filipovich AH et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002; 100: 2367-2373.
11. Ost A, Nilsson-Ardnor S, Henter JI. Autopsy findings in 27 children with haemophagocytic lymphohistiocytosis. Histopathology 1998; 32: 310-316.
12. Clementi R, Emmi L, Maccario R, Liotta F, Moretta L, Danesino C et al. Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood 2002; 100: 2266-2267.
13. Clementi R, zur Stadt U, Savoldi G, Varoitto S, Conter V, De Fusco C et al. Six novel mutations in the PRF1 gene in children with haemophagocytic lymphohistiocytosis. J Med Genet 2001; 38: 643-646.
14. McClain K, Gehrz R, Grierson H, Purtilo D, Filipovich A. Virus-associated histiocytic proliferations in children. Frequent association with Epstein-Barr virus and congenital or acquired immunodeficiencies. Am J Pediatr Hematol Oncol 1988; 10: 196-205.
15. De Vere-Tyndall A, Macauley D, Ansell BM. Disseminated intravascular coagulation complicating systemic juvenile chronic arthritis ('Still's disease'). Clin Rheumatol 1983; 2: 415-418.
16. Silverman ED, Miller III JJ, Bernstein B, Shafai T. Consumption coagulopathy associated with systemic juvenile rheumatoid arthritis. J Pediatr 1983; 103: 872-876.
17. Scott JP, Gerber P, Maryjowski MC, Pachman LM. Evidence for intravascular coagulation in systemic onset, but not polyarticular, juvenile rheumatoid arthritis. Arthritis Rheum 1985; 28: 256-261.
18. Dhote R, Simon J, Papo T, Detournay B, Sailler L, Andre MH et al. Reactive hemophagocytic syndrome in adult systemic disease: Report of twenty-six cases and literature review. Arthritis Rheum 2003; 49: 633-639.
19. Kumakura S, Ishikura H, Umegae N, Yamagata S, Kobayashi S. Autoimmune-associated hemophagocytic syndrome. Am J Med 1997; 102: 113-115.
20. Ramanan AV, Schneider R. Macrophage activation syndrome - what's in a name!. J Rheumatol 2003; 30: 2513-2516.
21. Ravelli A, Magni-Manzoni S, Pistorio A, Besana C, Foti T, Ruperto N et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 2005; 146: 598-604.
22. Pradalier A, Teillet F, Molitor JL, Drappier JC. Macrophage activation syndrome, hemophagocytic syndrome. Pathol Biol (Paris) 2004; 52: 407-414.
23. ten Cate R, Brinkman DM, van Rossum MA, Lankester AC, Bredius RG, Egeler MR et al. Macrophage activation syndrome after autologous stem cell transplantation for systemic juvenile idiopathic arthritis. Eur J Pediatr 2002; 161: 686.
24. Wulffraat M, de Kleer I, Brinkman D, ten Cate R, van der Net JJ, Rijkers GT et al. Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: Current results and perspectives. Transplant Proc 2002; 34: 2925-2926.
25. De Kleer IM, Brinkman DM, Ferster A, Abinun M, Quartier P, Van Der Net J et al. Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: Analysis of clinical effects, mortality, and transplant related morbidity. Ann Rheum Dis 2004; 63: 1318-1326.
26. Mouy R, Stephan JL, Pillet P, Haddad E, Hubert P, Prieur AM. Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: Report of five cases. J Pediatr 1996; 129: 750-754.
27. Emmenegger U, Frey U, Reimers A, Fux C, Semela D, Cottagnoud P et al. Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes. Am J Hematol 2001; 68: 4-10.
28. Vignes S, Le Moel G, Fautrel B, Wechsler B, Godeau P, Piette JC. Percentage of glycosylated serum ferritin remains low throughout the course of adult onset Still's disease. Ann Rheum Dis 2000; 59: 347-350.
29. Van Reeth C, Le Moel G, Lasne Y, Revenant MC, Agneray J, Kahn MF et al. Serum ferritin and isoferritins are tools for diagnosis of active adult Still's disease. J Rheumatol 1994; 21: 890-895.
30. Coffernils M, Soupart A, Pradier O, Feremans W, Neve P, Decaux G. Hyperferritinemia in adult onset Still's disease and the hemophagocytic syndrome. J Rheumatol 1992; 19: 1425-1427.
31. Kumakura S, Ishikura H, Munemasa S, Adachi T, Murakawa Y, Kobayashi S. Adult onset Still's disease associated hemophagocytosis. J Rheumatol 1997; 24: 1645-1648.
32. Grom AA, Villanueva J, Lee S, Goldmuntz EA, Passo MH, Filipovich A. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr 2003; 142: 292-296.
33. Wulffraat NM, Brinkman D, Ferster A, Opperman J, ten Cate R, Wedderburn L et al. Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis. Bone Marrow Transplant 2003; 32 (Suppl 1): S61-S64.
34. Esumi N, Ikushima S, Todo S, Imashuku S. Hyperferritinemia in malignant histiocytosis, virus-associated hemophagocytic syndrome and familial erythrophagocytic lymphohistiocytosis. A survey of pediatric cases. Acta Paediatr Scand 1989; 78: 268-270.
35. Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood 2002; 99: 3505-3516.
36. Rogers J, Lacroix L, Durmowitz G, Kasschau K, Andriotakis J, Bridges KR. The role of cytokines in the regulation of ferritin expression. Adv Exp Med Biol 1994; 356: 127-132.